GO
Loading...

Enter multiple symbols separated by commas

Government Agencies FDA

More

  • Morning After Pill Gets Backing From FDA Panel Thursday, 17 Jun 2010 | 4:19 PM ET
    FDA

    Federal health experts say a new type of morning-after pill that works longer than existing products is safe and effective.

  • 'Female Viagra' Pill Falls Short Says FDA Wednesday, 16 Jun 2010 | 4:07 PM ET
    FDA

    Federal health regulators said Wednesday the first pill designed to boost the female sex drive failed to make a significant impact on libido in two studies.

  • J&J Expands Medicine Recall Linked to Foul Odor Tuesday, 15 Jun 2010 | 6:30 PM ET
    johnson_johnson2_logo.jpg

    Johnson & Johnson is expanding a months-old recall of certain over-the-counter medicines due to complaints about a moldy smell that can cause nausea and sickness.

  • Johnson & Johnson Not Cooperating in Probe: Feds Friday, 11 Jun 2010 | 9:33 AM ET
    capitol_building_2_200.jpg

    A Congressional investigation into a recent recall of children’s Tylenol and other pediatric medicines has been stymied by the manufacturer, Johnson & Johnson, investigators say, raising the prospect that new measures — like issuing of subpoenas to compel cooperation — could be invoked.

  • Schuchter: Drug Rivals Work Together to Battle Melanoma Wednesday, 9 Jun 2010 | 4:04 PM ET
    Doctor holding test tube

    Thousands of researchers presented studies at the recent cancer forum, but none more significant than those for patients with advanced melanoma.

  • Muscle Milk

    Powerful protein supplements manufacturers like Muscle Milk and Myoplex were on an incredible trajectory, benefiting strongly from the workout world philosophy that protein building was not only good for energy but for recovery. But a damning Consumer Reports investigation threatens to cripple the burgeoning business that is a big part of the $2.7 billion sports nutrition marketplace.

  • Rethinking Cancer Treatment: No Quick Fix: Lichtenfeld Tuesday, 8 Jun 2010 | 12:39 PM ET
    doc_patient_shot_200.jpg

    There is no “quick fix” for cancer, no clear spot of light at the end of the tunnel. This cautious realization is that the fight against cancer is going to take more time than we thought.

  • drug_prices_sm.jpg

    Sales of a vaccine for late-stage prostate cancer, Dendreon’s Provenge, are expected to reach $1 billion in the first two years, analysts have predicted. This drug, one of several being showcased at the American Society of Clinical Oncologists meeting, represent a trend in which drugs treat a subgroup of cancer sufferers within the larger disease.

  • Cigarettes

    Goodbye, Marlboro Lights. Hello, Marlboro Gold Pack. "Light" cigarettes are going up in smoke by the end of June, but their names and packaging are getting a colorful makeover.

  • Questions for Makers on Defects in Drugs Thursday, 27 May 2010 | 2:32 PM ET
    tylenol_childrens_200.jpg

    For consumers who turned to drugstore house brands after the recall last month of liquid children’s Tylenol and other medicines made by a unit of Johnson & Johnson, there is yet more unsettling news.

  • FDA Investigating E. Coli at Arizona Lettuce Farm Friday, 7 May 2010 | 1:49 PM ET
    Romaine Lettuce

    Federal investigators are looking at a farm in Yuma, Ariz., as a possible source of a widespread E. coli outbreak in romaine lettuce, according to the distributor.

  • With Warning, a Hip Device Is Withdrawn Wednesday, 10 Mar 2010 | 11:21 AM ET
    X-ray of pelvis showing hip replacement

    A unit of Johnson & Johnson, just months after saying it was phasing out an artificial hip implant because of slowing sales, has warned doctors that the device appears to have a high early failure rate in some patients.

  • Glaxo Gets Aggressive On Avandia Wednesday, 24 Feb 2010 | 4:03 PM ET
    The company logo of GlaxoSmithKline, is seen on the headquarters building in London, Wednesday May 10, 2006. GlaxoSmithKline PLC said Wednesday it has been granted a High Court injunction against animal rights activists who sent threats to the drugmaker's shareholders, barring them from sending more letters or revealing private information about the investors. (AP Photo/Alastair Grant)

    On day five of Avandiagate, GlaxoSmithKline communiques about the brouhaha surrounding the controversial diabetes drug now number six.

  • Jobs Bill Is 'Not Bipartisan,' GOP Sen. Grassley Says Tuesday, 23 Feb 2010 | 10:42 AM ET
    money_capital.jpg

    Congress could have passed a more sweeping jobs bill with larger bipartisan support if Democrats had been more willing to work with Republicans, Sen. Charles Grassley told CNBC.

  • Bank of America flag

    The New York Attorney General's office is filing civil charges against Bank of America and its former CEO Ken Lewis, saying the bank misled investors about Merrill Lynch when it acquired the Wall Street bank in late 2008.

  • Eyeing An Opportunity For Genentech Monday, 1 Feb 2010 | 2:28 PM ET

    For Roche/Genentech the timing could not be worse. At a time when cutting healthcare costs could still end up being put back on the frontburner in Washington comes a study showing how to possibly save a heckuva lot of money.

  • Johnson & Johnson Results Top Wall Street Views Tuesday, 26 Jan 2010 | 9:38 AM ET
    Johnson & Johnson

    Johnson & Johnson reported Tuesday better-than-expected fourth quarter sales and earnings, helped by a recovering global economy, but provided a 2010 profit forecast range that barely reached Wall Street projections.

  • Investors Want Aid From Stanford-Linked Congressman Wednesday, 30 Dec 2009 | 6:44 PM ET
    R. Allen Stanford

    A group of investors in Allen Stanford's alleged Ponzi scheme are demanding a powerful Texas congressman give them the same kind of support he showed Stanford when regulators shut down the alleged scam in February.

  • Stanford Bail Denied, Feds Probe Congressional Ties Sunday, 27 Dec 2009 | 3:54 PM ET
    Allen Stanford

    A federal judge has denied an emergency request by attorneys for indicted billionaire Allen Stanford to free their client on bail. 

  • Stocks Close Out Solid Holiday Week Thursday, 24 Dec 2009 | 1:00 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks closed higher as a holiday rally got a further push from big technology, banks and commodities, though most investors took Christmas Eve off.